Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI).

about

Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI).

Item

http://www.wikidata.org/entity/Q55005321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Phase I study of neoadjuvant c ...... gastric cancer (Neo G-SOX PI).

@en

Phase I study of neoadjuvant c ...... ocally advanced gastric cancer

@nl

type

Item

label

Phase I study of neoadjuvant c ...... gastric cancer (Neo G-SOX PI).

@en

Phase I study of neoadjuvant c ...... ocally advanced gastric cancer

@nl

prefLabel

Phase I study of neoadjuvant c ...... gastric cancer (Neo G-SOX PI).

@en

Phase I study of neoadjuvant c ...... ocally advanced gastric cancer

@nl

P1476

Phase I study of neoadjuvant c ...... gastric cancer (Neo G-SOX PI).

@en

P2093

Akihito Tsuji

http://www.w3.org/2001/XMLSchema#string

Akira Miki

http://www.w3.org/2001/XMLSchema#string

Chihiro Ichikawa

http://www.w3.org/2001/XMLSchema#string

Hiroki Hashida

http://www.w3.org/2001/XMLSchema#string

Hironaga Satake

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Hisateru Yasui

http://www.w3.org/2001/XMLSchema#string

Kenta Murotani

http://www.w3.org/2001/XMLSchema#string

Masahito Kotaka

http://www.w3.org/2001/XMLSchema#string

Masato Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer.

Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

P304

e000130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2016-000130

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28761726

http://www.w3.org/2001/XMLSchema#string

P932

5519803

http://www.w3.org/2001/XMLSchema#string